Umoja Biopharma, Inc., a clinical-stage biotechnology company, sees a different future for oncology and autoimmunity treatment—a future that provides improved patient access and alleviates the burdens ...
GERMANTOWN, Md., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Orgenesis Inc. (ORGS) (“Orgenesis” or the “Company”), a global leader in decentralized cell and gene therapies (CGTs), today announced that the ...